87 related articles for article (PubMed ID: 3782790)
1. Pertussigen in vivo enhances antigen-specific production in vitro of lymphokine that stimulates macrophage procoagulant activity and plasminogen activator.
de Moerloose PA; Hamilton JA; Sewell WA; Vadas MA; Mackay IR
J Immunol; 1986 Dec; 137(11):3528-33. PubMed ID: 3782790
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of delayed-type hypersensitivity by pertussigen or cyclophosphamide with release of different lymphokines.
Sewell WA; de Moerloose PA; Hamilton JA; Schrader JW; Mackay IR; Vadas MA
Immunology; 1987 Aug; 61(4):483-8. PubMed ID: 3127325
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of the enhancement of delayed-type hypersensitivity by pertussigen.
Sewell WA; Munoz JJ; Scollay R; Vadas MA
J Immunol; 1984 Oct; 133(4):1716-22. PubMed ID: 6206132
[TBL] [Abstract][Full Text] [Related]
4. Macrophage procoagulant activity as a measure of cell-mediated immunity in the mouse.
Geczy CL; Farram E; Moon DK; Meyer PA; McKenzie IF
J Immunol; 1983 Jun; 130(6):2743-9. PubMed ID: 6189899
[TBL] [Abstract][Full Text] [Related]
5. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
Farram E; Geczy CL; Moon DK; Hopper K
J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
[TBL] [Abstract][Full Text] [Related]
6. Pertussigen enhances antigen-driven interferon-gamma production by sensitized lymphoid cells.
Sewell WA; de Moerloose PA; McKimm-Breschkin JL; Vadas MA
Cell Immunol; 1986 Feb; 97(2):238-47. PubMed ID: 3091271
[TBL] [Abstract][Full Text] [Related]
7. Macrophages as effector cells of protective immunity in murine schistosomiasis. VI. T cell-dependent, lymphokine-mediated, activation of macrophages in response to Schistosoma mansoni antigens.
James SL; Lazdins JK; Hieny S; Natovitz P
J Immunol; 1983 Sep; 131(3):1481-6. PubMed ID: 6350456
[TBL] [Abstract][Full Text] [Related]
8. Lymphokine-induced secretion of plasminogen activator by murine macrophages.
Klimetzek V; Sorg C
Eur J Immunol; 1977 Mar; 7(3):185-7. PubMed ID: 862658
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lymphocyte recirculation.
Spangrude GJ; Braaten BA; Daynes RA
J Immunol; 1984 Jan; 132(1):354-62. PubMed ID: 6537815
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines.
Thomson AW; Moon DK; Geczy CL; Nelson DS
Immunology; 1983 Feb; 48(2):291-9. PubMed ID: 6337088
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the intensity, persistence, and passive transfer of delayed-type hypersensitivity lesions by pertussigen in mice.
Sewell WA; Munoz JJ; Vadas MA
J Exp Med; 1983 Jun; 157(6):2087-96. PubMed ID: 6304228
[TBL] [Abstract][Full Text] [Related]
12. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
13. T-cell responses to orally administered antigens. Study of the kinetics of lymphokine production after single and multiple feeding.
Hoyne GF; Thomas WR
Immunology; 1995 Feb; 84(2):304-9. PubMed ID: 7751007
[TBL] [Abstract][Full Text] [Related]
14. Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.
Thomson AW; Moon DK; Inoue Y; Geczy CL; Nelson DS
Immunology; 1983 Feb; 48(2):301-8. PubMed ID: 6822404
[TBL] [Abstract][Full Text] [Related]
15. Expression of macrophage procoagulant activity in murine systemic lupus erythematosus.
Cole EH; Sweet J; Levy GA
J Clin Invest; 1986 Oct; 78(4):887-93. PubMed ID: 3760190
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of chemotactic lymphokine production. I. Selective potentiation of eosinophil chemotactic lymphokine production in alum hydroxy gel- and Bordetella pertussis vaccine-treated guinea pigs.
Sakata K; Tashiro K; Hirashima M; Hayashi H
J Immunol; 1985 Nov; 135(5):3463-7. PubMed ID: 2864377
[TBL] [Abstract][Full Text] [Related]
17. Influence of tumour carriage on the production of lymphokines affecting macrophage behaviour.
McIntosh LC; Morrice LM; Udagawa Y; Thomson AW
Immunology; 1986 Mar; 57(3):359-65. PubMed ID: 3485563
[TBL] [Abstract][Full Text] [Related]
18. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
19. Biosynthesis of macrophage activation factor.
Baliga BS; Rorher SD; Maumenee AE; Peterson RD
Lymphokine Res; 1986; 5(2):141-56. PubMed ID: 3517510
[TBL] [Abstract][Full Text] [Related]
20. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
Geczy CL; Hopper KE
J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
